-
D. Castellano, X. Garcia del Muro, J. L. Pérez-Gracia, J. L. González-Larriba, M. V. Abrio, M. A. Ruiz, A. Pardo, C. Guzmán, S. Díaz Cerezo, and E. Grande
-
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-
as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
Annals of Oncology Advance Access published on June 23, 2009
Ann Oncol 2009 20: 1803-1812; doi:10.1093/annonc/mdp067
[Abstract]
[FREE Full Text]
[PDF]
OPEN ACCESS
|